Marshall Wace, LLP Amryt Pharma PLC Transaction History

Marshall Wace, LLP

  • $77.3 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$6.85 - $8.87 $89,008 - $115,256
-12,994 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$6.3 - $10.86 $81,862 - $141,114
12,994 New
12,994 $108,000
Q4 2021

Feb 14, 2022
SELL
$9.44 - $12.24 $1.36 Million - $1.76 Million
-143,629 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$9.63 - $12.47 $1.38 Million - $1.79 Million
143,629 New
143,629 $1.74 Million

Others Institutions Holding AMYT

# of Institutions
5
Shares Held
142K
Call Options Held
0
Put Options Held
0
View Full List

About Amryt Pharma plc

AMYT Quotes by TradingView
  • Ticker AMYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 64,177,000
  • Description
  • Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with ...
More about AMYT
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email